Sabag Mark — SEC Form 4 filings
SEC reporting owner CIK 1721442. 17 Form 4 filings on record with FilingPulse; latest filed 2026-05-04.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-02-01 to 2026-05-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 6 filings — 1,038,715 shares, $23,483,648 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: sale of 337,915 shares @ $18.04 ($6,097,304) in TEVA PHARMACEUTICAL INDUSTRIES LTD, filed 2025-05-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | See "Remarks" | 17 | — | 7 legs · 1,038,715 sh · $23,483,648 | 38 |
Form 4 filings — Sabag Mark
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-04 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 144,180 @ $34.99 | EDGAR |
| 2026-03-19 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 62,102 @ $30.14 | EDGAR |
| 2026-03-09 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 15,723 · Option exercise (M): 15,723 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 33,512 · Option exercise (M): 18,601 · Option exercise (M): 33,512 (derivative) @ $0 · Option exercise (M): 18,601 (derivative) @ $0 · Grant/award (A): 30,385 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 24,900 · Option exercise (M): 141,478 · Option exercise (M): 24,900 (derivative) @ $0 · Option exercise (M): 141,478 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 141,478 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 118,724 @ $18.61 · Sale (S): 118,724 @ $28.75 · Sale (S): 98,168 @ $28.70 · Option exercise (M): 118,724 (derivative) @ $0 | EDGAR |
| 2025-05-12 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 337,915 @ $18.04 | EDGAR |
| 2025-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 23,765 · Option exercise (M): 23,765 (derivative) @ $0 · Grant/award (A): 62,893 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 33,512 · Option exercise (M): 18,601 · Option exercise (M): 183,169 · Option exercise (M): 33,512 (derivative) @ $0 · Option exercise (M): 18,601 (derivative) @ $0 · Option exercise (M): 183,169 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 24,900 · Option exercise (M): 24,900 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 177,626 @ $16.25 | EDGAR |
| 2025-01-30 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 183,169 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 23,764 · Option exercise (M): 58,133 · Sale (S): 100,000 @ $13.52 · Option exercise (M): 23,764 (derivative) @ $0 · Option exercise (M): 58,133 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 24,900 · Option exercise (M): 33,512 · Option exercise (M): 24,900 (derivative) @ $0 · Option exercise (M): 33,512 (derivative) @ $0 · Grant/award (A): 74,404 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 20,599 · Option exercise (M): 20,599 (derivative) @ $0 | EDGAR |
| 2024-02-01 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 58,133 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1721442 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →